Over the last five years, a confluence of trends have combined to reshape the reality of clinical research. COVID-19 pushed decentralised trials into the mainstream.
As has become tradition in the pharma and biotech world, 2024 kicked off with a bang as experts from around the globe gathered in San Francisco for the 42nd annual JP Morgan Health Conferen
Behind every successfully approved treatment lies a nexus of clinical research activities comprising myriad drug types, trial phases, and packaging needs across diverse geographical locatio
The story of CRISPR’s development, from its humble beginnings as a bacterial defence mechanism to its current status as a groundbreaking tool for gene editing and beyond, is a fascinating j
South Korea’s Hyundai Bioscience is preparing to start clinical trials of what it hopes could become the first antiviral treatment for dengue fever, a mosquito-borne viral
It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.